267 related articles for article (PubMed ID: 27586013)
1. The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.
Maekawa T; Komori K; Kodama A; Banno H; Narita H; Sugimoto M
Surg Today; 2017 Mar; 47(3):293-300. PubMed ID: 27586013
[TBL] [Abstract][Full Text] [Related]
2. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
3. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
4. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion.
Kim SY; Min SK; Ahn S; Min SI; Ha J; Kim SJ
J Vasc Surg; 2012 Jan; 55(1):90-7. PubMed ID: 21944915
[TBL] [Abstract][Full Text] [Related]
6. Duplex selection facilitates single point-of-service endovascular and surgical management of aortoiliac occlusive disease.
Back MR; Bowser AN; Schmacht DC; Johnson BL; Bandyk DF
Ann Vasc Surg; 2002 Sep; 16(5):566-74. PubMed ID: 12183774
[TBL] [Abstract][Full Text] [Related]
7. Importance of the profunda femoris upon patency following aortoiliac procedures.
Balasundaram N; Whitrock JN; Braet DJ; Vogel TR; Bath JM
J Vasc Surg; 2022 Jul; 76(1):180-187.e3. PubMed ID: 35276269
[TBL] [Abstract][Full Text] [Related]
8. The durability of endovascular treatment of multisegment iliac occlusive disease.
Powell RJ; Fillinger M; Bettmann M; Jeffery R; Langdon D; Walsh DB; Zwolak R; Hines M; Cronenwett JL
J Vasc Surg; 2000 Jun; 31(6):1178-84. PubMed ID: 10842155
[TBL] [Abstract][Full Text] [Related]
9. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
Nishibe T; Kondo Y; Dardik A; Muto A; Koizumi J; Nishibe M
J Cardiovasc Surg (Torino); 2009 Aug; 50(4):493-9. PubMed ID: 19734834
[TBL] [Abstract][Full Text] [Related]
10. One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass.
Krievins DK; Halena G; Scheinert D; Savlovskis J; Szopiński P; Krämer A; Ouriel K; Nair K; Holden A; Schmidt A
J Vasc Surg; 2020 Nov; 72(5):1648-1658.e2. PubMed ID: 32276015
[TBL] [Abstract][Full Text] [Related]
11. Single-center experience in endovascular treatment for infrainguinal bypass obstructions.
Baumann F; Engelberger RP; Makaloski V; Do DD; Baumgartner I; Diehm N
J Vasc Interv Radiol; 2012 Aug; 23(8):1055-62. PubMed ID: 22840804
[TBL] [Abstract][Full Text] [Related]
12. Open and Endovascular Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Lesions: What Determines the Rate of Restenosis?
Shen CY; Liu YF; Li QL; Zhang YB; Jiao Y; Krokidis ME; Zhang XM
Chin Med J (Engl); 2015 Nov; 128(22):3035-42. PubMed ID: 26608983
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of iliac inflow repair in patients with concomitant iliac and superficial femoral artery occlusive disease.
Akamatsu D; Goto H; Kamei T; Miyagi S; Tsuchida K; Kawamura K; Tajima Y; Umetsu M; Watanabe T; Ohuchi N
Asian J Surg; 2017 Nov; 40(6):475-480. PubMed ID: 27451009
[TBL] [Abstract][Full Text] [Related]
14. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
[TBL] [Abstract][Full Text] [Related]
15. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study.
Guo X; Xue G; Huang X; Xie H; Liang W; Zhang J; Lin F; Yao T
BMC Cardiovasc Disord; 2015 May; 15():44. PubMed ID: 26022244
[TBL] [Abstract][Full Text] [Related]
17. Endovascular treatment of common femoral artery obstructions.
Baumann F; Ruch M; Willenberg T; Dick F; Do DD; Keo HH; Baumgartner I; Diehm N
J Vasc Surg; 2011 Apr; 53(4):1000-6. PubMed ID: 21215567
[TBL] [Abstract][Full Text] [Related]
18. Arterial surgery in intermittent claudication.
Watt JK; Gillespie G; Pollock JG; Reid W
Br Med J; 1974 Jan; 1(5896):23-6. PubMed ID: 4808817
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease.
Chang RW; Goodney PP; Baek JH; Nolan BW; Rzucidlo EM; Powell RJ
J Vasc Surg; 2008 Aug; 48(2):362-7. PubMed ID: 18572359
[TBL] [Abstract][Full Text] [Related]
20. Ten-year clinical outcomes for patients undergoing lower extremity endovascular interventions.
Katsuki T; Yamaji K; Hiramori S; Tomoi Y; Soga Y; Ando K
J Vasc Surg; 2020 Nov; 72(5):1626-1635.e3. PubMed ID: 32278575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
